Aktie A2PYUT SUVEN PHARMACEUTICALS LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Suven Pharmaceuticals Limited Bombay S.E.

Aktien

A2PYUT

INE03QK01018

SUVENPHAR

Verzögert Bombay S.E.
Andere Börsenplätze
 08:09:13 21.05.2024 		% 5 Tage % 1. Jan.
635.6 INR -1.56% Intraday Chart für Suven Pharmaceuticals Limited -2.19% -12.47%
05.03. Transcript : Cohance Lifesciences Limited, Suven Pharmaceuticals Limited - M&A Call
01.03. INDIA STOCKS-Indische Aktien steigen aufgrund des starken Inlandswachstums und stabiler US-Inflationsdaten RE

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Suven Pharmaceuticals Limited Announces Shifting of Registered Office
Indian shares set to rise on strong domestic growth, in-line US inflation data
Suven Pharmaceuticals Limited agreed to acquire Cohance Lifesciences Limited for INR 81,340.421103 million
US FDA Clears Suven Pharmaceuticals' API and Formulations Plants in Hyderabad, India
Suven Pharmaceuticals' Consolidated Net Profit Declines in Fiscal Q3
Suven Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Suven Pharmaceuticals CFO Steps Down
Suven Pharmaceuticals Limited Announces CFO Changes, Effective January 2, 2024
Suven Pharmaceuticals Names CFO
Suven Pharmaceuticals Limited Appoints Dr. Vetukuri Venkata Naga Kali Vara Prasada Raju as Managing Director
Suven Pharmaceuticals Limited Announces Board Appointments
Suven Pharmaceuticals Limited Approves Interim Dividend for the Financial Year 2023-24
Suven Pharmaceuticals Limited Proposes Interim Dividend for the Financial Year 2022-23
Suven Pharmaceuticals Posts Gains in Fiscal Q2 Consolidated Profit
Suven Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Berhyanda Limited completed the acquisition of 0.001% stake in Suven Pharmaceuticals Limited for INR 1.3 million.
Suven Pharmaceuticals Limited Announces Board Changes
Advent International Corporation completed the acquisition of 50.1% stake in Suven Pharmaceuticals Limited from Jasti Family.
INDIA STOCKS-India's Nifty 50, Sensex scale new peaks on hopes of Fed rate pause
Indian shares set to open higher on rising hopes of a Fed rate pause
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. SUVENPHAR Aktie
  4. A2PYUT Aktie
  5. Nachrichten Suven Pharmaceuticals Limited
  6. Andere Sprachen